- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04791163
Above-knee Socket Evaluation : Sub-ischial vs Ischial Containment (P20-EMBSUBI)
August 8, 2022 updated by: Proteor Group
AK Socket Evaluation : Sub-ischial vs Ischial Containment. Multi-center Randomised Crossover Study
Socket is key to provide comfort and function to lower limb amputees.
A new socket, the sub-ischial socket, will be compared to "traditional" ischial containment sockets, based on comfort self-evaluation, and locomotor capacities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Subjects wearing ischail containment sockets will be proposed to enter the research.
They will be provided and fitted with a sub-ischial socket.
Randomly, they will use one or the other socket for four weeks, then be tested : finctional test and questionnaires.
After this testing session, they will use the other socket, and be re-tested accordingly.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49100
- Les Capucins
-
Bruges, France, 33523
- UGECAM La Tour de Gassies
-
Colomiers, France, 31771
- Clinique du Cabirol
-
Hyères, France, 83418
- Hôpital Léon Berard
-
Nancy, France, 54000
- UGECAM - IRR Nancy
-
Paris, France, 75007
- Institution Nationale des Invalides
-
Ploemeur, France, 56275
- Centre Mutualiste de Kerpape
-
Saint-Herblain, France, 44818
- UGECAM La Tourmaline
-
Vannes, France, 56000
- CHBA Vannes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- can give informed consent
- aged 18 or more
- above-knee amputee, wearing a definitive ischial containment socket
- stump longer than 16cm
- wearing a liner, whatever the suspension system
- able to walk (d4600, d4601, d4602, d4608 accordinf to IFC)
- unilaterla or bilateral amputee
- able to done the socket standing
- whatever the etiology
Exclusion Criteria:
- protected person
- pregnant woman or nursing mother
- subject having comorbidities heavily impacting feeling or socket donning
- allergic to silicon
- suffering from big volume variations in a same day
- infecté stump (may lead to lymphatic problems)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sub-ischial socket
Start using the sub-ischial socket for four weeks and be tested with this socket.
|
The subject will wear the socket for 4 weeks, and then reply questionnaires and achieve a 2-minute walking test
|
|
Active Comparator: Ischial containment socket
Start using the ischial containment socket for four weeks and be tested with this socket.
|
The subject will wear the socket for 4 weeks, and then reply questionnaires and achieve a 2-minute walking test
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort evaluation
Time Frame: 1 minute
|
Socket Comfort Score (SCS)
|
1 minute
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort evaluation in various situations
Time Frame: 1 minute
|
Same question for four detailed situations
|
1 minute
|
|
Locomotor capability
Time Frame: 5 minutes
|
PLUS-M questionnaire and 2-minute walking test
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2021
Primary Completion (Actual)
July 1, 2022
Study Completion (Actual)
July 1, 2022
Study Registration Dates
First Submitted
March 8, 2021
First Submitted That Met QC Criteria
March 8, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
August 9, 2022
Last Update Submitted That Met QC Criteria
August 8, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2020-A03303-36
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.